ARQT
Arcutis Biotherapeutics, Inc.C5415-min delayed · EOD close23.85 +0.42% upas of 2026-09-02mkt cap $3.0B
Pharmaceutical Preparations · SIC 2834 · CIK 0001787306
Who’s trading ARQT
Corporate insiders on Form 4, House members under the STOCK Act, and the funds reporting a position in their 13F.
Corporate insiders
0 bought · 2 sold
$0 bought · $584K sold
Congress
2 buys · 1 sells
$16K bought · $8K sold, at range midpoints
Funds holding
2 filers
$31.9M reported
The counts above are free. Who they are, and what each of them traded, is part of Pro — see what it includes.
Form 4 insider trades are exact and filed within two business days. Congressional figures are range midpoints disclosed up to 45 days after the trade, and 13F positions are a quarter-end snapshot. All three are a record of what was disclosed, not a signal.